Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Accelerate Diagnostics, Inc (AXDX)
|
Add to portfolio |
|
|
|
| Price: |
$5.15
| | Metrics |
| OS: |
14.4
|
M
| |
|
|
| Market cap: |
$74
|
M
| |
|
|
|
Net debt:
|
$3.73
|
M
| |
|
|
|
EV:
|
$77.7
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($54.4)
|
M
| |
|
|
|
EBIT
|
($57.6)
|
M
| |
|
|
| EPS |
($3.50)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 12.8 | 11.8 | 11.2 | 9.3 | 5.7 | 0.9 | 0.5 | 0.1 |
| Revenue growth | 8.2% | 5.5% | 20.1% | 64.0% | 524.4% | 83.8% | 236.1% | 20.5% |
| Cost of goods sold | 9.4 | 12.2 | 6.7 | 4.9 | 3.2 | 1.0 | -1.0 | -0.6 |
| Gross profit | 3.3 | -0.4 | 4.5 | 4.4 | 2.5 | -0.1 | 1.4 | 0.8 |
| Gross margin | 25.9% | -3.2% | 39.9% | 47.3% | 43.8% | -10.4% | 292.7% | 540.1% |
| Selling, general and administrative | 39.2 | 49.2 | 46.9 | 51.9 | 55.2 | 45.1 | 37.2 | |
| Research and development | 26.9 | 21.9 | 21.3 | 25.3 | 27.6 | 22.3 | 29.6 | 27.1 |
| General and administrative | | | | | | | | 18.6 |
| EBITA | -62.8 | -71.6 | -63.7 | -72.8 | -80.4 | -64.2 | -65.3 | -44.9 |
| EBITA margin | -492.5% | -607.4% | -570.5% | -783.4% | -1417.4% | -7068.7% | -13218.8% | -30538.8% |
| Amortization of intangibles | | | | | | | | 0.0 |
| EBIT | -62.8 | -71.6 | -63.7 | -72.8 | -80.4 | -64.2 | -65.3 | -44.9 |
| EBIT margin | -492.5% | -607.4% | -570.5% | -783.4% | -1417.4% | -7068.7% | -13218.8% | -30545.6% |
| Pre-tax income | -62.6 | -77.7 | -78.2 | -84.4 | -88.1 | -63.5 | -66.1 | -45.5 |
| Income taxes | -0.1 | 0.0 | 0.0 | -0.1 | 0.2 | 0.5 | 0.3 | 0.0 |
| Tax rate | 0.1% | | | 0.1% | | | | 0.0% |
| Net income | -62.5 | -77.7 | -78.2 | -84.3 | -88.3 | -64.0 | -66.4 | -45.5 |
| Net margin | -490.1% | -659.5% | -700.5% | -906.8% | -1557.8% | -7051.5% | -13436.0% | -30951.0% |
| |
| Diluted EPS | ($0.76) | ($1.26) | ($1.40) | ($1.55) | ($1.62) | ($1.18) | ($1.29) | ($1.01) |
| Shares outstanding (diluted) | 82.2 | 61.7 | 56.0 | 54.5 | 54.5 | 54.1 | 51.3 | 45.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|